These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21634306)

  • 1. Leucocytoclastic vasculitis in severe ulcerative colitis.
    Martin D; Handler T; McDermott J
    Mil Med; 2011 May; 176(5):581-3. PubMed ID: 21634306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis associated with leukocytoclastic vasculitis of the skin.
    Tripodi Cutrì F; Salerno R; Lo Schiavo A; Gravina AG; Romano M; Ruocco E
    Dig Liver Dis; 2009 Jul; 41(7):e42-4. PubMed ID: 18799375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
    López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
    Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcerative colitis presenting as leukocytoclastic vasculitis of skin.
    Akbulut S; Ozaslan E; Topal F; Albayrak L; Kayhan B; Efe C
    World J Gastroenterol; 2008 Apr; 14(15):2448-50. PubMed ID: 18416478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukocytoclastic vasculitis associated with Crohn's disease].
    Plaza Santos R; Jaquotot Herranz M; Froilán Torres C; Poza Cordón J; Casado Verrier B; de Tena Díaz-Agero FL; Vázquez López P; Suárez de Parga JM
    Gastroenterol Hepatol; 2010; 33(6):433-5. PubMed ID: 19818534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pustular vasculitis and superficial bullous pyoderma gangrenosum in a patient with ulcerative colitis.
    Lazarov A; Amichai B; Halevy S
    Cutis; 1995 Nov; 56(5):297-300. PubMed ID: 8565618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pyoderma gangrenosum with lung involvement treated with infliximab].
    Deregnaucourt D; Buche S; Coopman S; Basraoui D; Turck D; Delaporte E
    Ann Dermatol Venereol; 2013 May; 140(5):363-6. PubMed ID: 23663708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
    Bello C; Belaiche J; Louis E; Reenaers C
    J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of ulcerative colitis].
    Rammert Ch; Kullak-Ublick GA
    Ther Umsch; 2003 Mar; 60(3):145-50. PubMed ID: 12693317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal therapy for severe ulcerative colitis?
    MacDermott RP; Green JA; Ashley CC
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S228-31. PubMed ID: 18816769
    [No Abstract]   [Full Text] [Related]  

  • 17. Ulcerative colitis: conservative management and long-term effects.
    Kühbacher T; Schreiber S; Fölsch UR
    Langenbecks Arch Surg; 2004 Oct; 389(5):350-3. PubMed ID: 15133672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocytoclastic vasculitis as onset symptom of ulcerative colitis.
    Iannone F; Scioscia C; Musio A; Piscitelli D; Lapadula G
    Ann Rheum Dis; 2003 Aug; 62(8):785-6. PubMed ID: 12860742
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
    Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
    J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal maintenance treatment for ulcerative colitis?
    Cohen RD
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S236-7. PubMed ID: 18816679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.